In this podcast Professor Susan O’Brien from Irvine, USA, explains the importance she places on long-term safety and efficacy data when making treatment decisions in R/R CLL. She also describes how she talks through treatment options with patients to determine the management approach best suited to their individual needs. Professor O’Brien is Associate Director for ...
Podcast: Long-term data and patient priorities inform R/R CLL management
9 Sep 2021
Sponsored by Janssen-Cilag Pty Ltd